Cancer Research Cell Death Mechanisms and Cancer Therapy  Sign up for Cancer Research eTOC's
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 52, 4514-4521, August 15, 1992]
© 1992 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arita, Y.
Right arrow Articles by Weinstein, I. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arita, Y.
Right arrow Articles by Weinstein, I. B.

Growth of Human Melanocyte Cultures Supported by 12-O-Tetradecanoylphorbol-13-acetate Is Mediated through Protein Kinase C Activation1

Yuko Arita2, Kevin R. O'Driscoll2 and I. Bernard Weinstein3

Comprehensive Cancer Center and Institute of Cancer Research, Columbia University, New York, New York 10032 [K. R. O'D., I. B. W.], and Medical Research Division, Lederle Laboratories, American Cyanamid Company, Pearl River, New York 10965 [Y. A.]

To investigate the role of protein kinase C (PKC) in the 12-O-tetradecanoylphorbol-13-acetate (TPA)-dependent growth of human melanocytes, we analyzed the effects of phorbol ester treatment on both PKC expression and growth control in these cells. We found that established cultures of normal melanocytes contain the PKC{alpha}, PKCß, and PKC{varepsilon} isoforms. The abilities of various phorbol ester compounds to stimulate DNA synthesis in these cultured melanocytes correlated with their known potencies for activation of PKC and tumor promotion. Dose-response studies revealed that the most effective TPA concentration for stimulation of DNA synthesis and growth of melanocytes (10 ng/ml TPA) also supported a relatively high level of PKC enzyme activity, increased membrane association of the PKC{alpha} and PKC{varepsilon} isoforms, and led to a high level of phosphorylation of a major PKC substrate, the myristoylated alanine-rich C kinase substrate (MARCKS) protein. Melanocytes incubated for 48 h with TPA at a higher concentration (100 ng/ml TPA) exhibited suboptimal TPA-stimulated DNA synthesis (28% of maximal) and decreased phosphorylation of the MARCKS substrate protein (50% of maximal). Furthermore, treatment of melanocytes with 100 ng/ml TPA for 48 h resulted in a marked decrease in total PKC enzyme activity and the loss of expression of the PKC{alpha} and PKC{varepsilon} isoforms in both the cytosol and membranebound fractions, when examined by immunoblot analysis. These results, taken together, suggest that continuous activation of PKC by TPA, rather than the loss of PKC due to TPA-induced down-regulation, is responsible for the growth-stimulatory effects of phorbol esters on normal human melanocytes. Additionally, the conditioned medium from TPA-treated human melanocytes stimulated DNA synthesis in quiescent melanocytes and human melanoma cells, thus suggesting that activation of the PKC signaling pathway in melanocytes leads to the production of an autocrine growth factor. These findings may be relevant to the autonomous growth of malignant melanomas.

1 Funding was provided by the American Cancer Society (Grant BC-560 to M. Eisinger), the National Cancer Institute (Grant CA 087422 to M. Eisinger and Grant CA 26056 to I. B. W.), and a National Research Service Award (CA09529-05 to K. R. O'D.).

2 Y. A. and K. R. O'D. contributed equally to this work and can both be considered first authors.

3 To whom requests for reprints should be addressed, at the Comprehensive Cancer Center, Columbia University, 701 West 168th St., HHSC Room 1509, New York, NY 10032.

Received 3/12/92. Accepted 6/ 4/92.




This article has been cited by other articles:


Home page
Cancer Res.Home page
S.-J. Cozzi, P. G. Parsons, S. M. Ogbourne, J. Pedley, and G. M. Boyle
Induction of Senescence in Diterpene Ester-Treated Melanoma Cells via Protein Kinase C-Dependent Hyperactivation of the Mitogen-Activated Protein Kinase Pathway.
Cancer Res., October 15, 2006; 66(20): 10083 - 10091.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. Agadir, G.-q. Chen, F. Bost, Y. Li, D. Mercola, and X.-k. Zhang
Differential Effect of Retinoic Acid on Growth Regulation by Phorbol Ester in Human Cancer Cell Lines
J. Biol. Chem., October 15, 1999; 274(42): 29779 - 29785.
[Abstract] [Full Text] [PDF]


Home page
J. Cell Sci.Home page
C. Carsberg, H. Warenius, and P. Friedmann
Ultraviolet radiation-induced melanogenesis in human melanocytes. Effects of modulating protein kinase C
J. Cell Sci., January 9, 1994; 107(9): 2591 - 2597.
[Abstract] [PDF]


Home page
J. Cell Sci.Home page
T Hirobe
Effects of activators (SC-9 and OAG) and inhibitors (staurosporine and H-7) of protein kinase C on the proliferation of mouse epidermal melanoblasts in serum-free culture
J. Cell Sci., January 6, 1994; 107(6): 1679 - 1686.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1992 by the American Association for Cancer Research.